The five D's of botulinum toxin: Doses, dilution, diffusion, duration and dogma

Journal of Cosmetic and Laser Therapy

Volumn 10, Issue 2, 2008, Pages 93-102

  Paula De Sa Earp, Ana ^a,b   Marmur, Ellen S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE   (Brazil)

Author keywords

Botulinum toxin; Dynamic rhytids

Indexed keywords

BENZYL ALCOHOL; BOTULINUM TOXIN; HUMAN ALBUMIN; LIDOCAINE; SODIUM CHLORIDE;

BLEPHAROSPASM; DIFFUSION; DILUTION; DRUG EFFICACY; DRUG SAFETY; EXTRAOCULAR MUSCLE; EYEBROW; FACE MUSCLE; FOREHEAD; HUMAN; HYPERHIDROSIS; INJECTION SITE; MEDICAL INFORMATION; MEDICAL PERSONNEL; MEDICAL PRACTICE; NECK MUSCLE; NOSE APEX; PATIENT SELECTION; PLATYSMA MUSCLE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STORAGE TEMPERATURE; TREATMENT INDICATION; WRINKLE;

BOTULINUM TOXIN TYPE A; COSMETIC TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG STORAGE; FACE; HUMANS; NECK; PATIENT SELECTION; SKIN AGING;

EID: 45849118297     PISSN: 14764172     EISSN: 14764180     Source Type: Journal    
DOI: 10.1080/14764170701883660     Document Type: Review

References (36)

1. Morgan JC, Iyer SS, Moser ET, Singer C, Sethi KD. Botulinum toxin A during pregnancy: A survey of treating physicians. J Neurol Neurosurg Psychiatry. 2006;77:117-19.
2. De Oliveira Monteiro E. Botulinum toxin and pregnancy. Skinmed. 2006;5:308.
3. Ward SJ, Harrop-Griffiths W. Botox injections and monitoring neuromuscular blockade. Anaesthesia. 2006;61:726.
4. Klein AW. Dilution and storage of botulinum toxin. Dermatol Surg. 1998;24:1179-80.
5. Hankins CL, Strimling R, Rogers GS. Botulinum A toxin for glabellar wrinkles. Dose and Response. Dermatol Surg. 1998;24:1181-3.
6. Trindade De Almeida AR, Kadunc BV, Di Chiacchio N, Neto DR. Foam during reconstitution does not affect the potency of Botulinum toxin. Dermatol Surg. 2003;29:530-1.
7. Alam M, Yoo SS, Wrone DA, White LE, Kim JY. Sterility assessment of multiple use botulinum A exotoxin vials: A prospective simulation. J Am Acad Dermatol. 2006;55:272-5.
8. Hexsel DM, De Almeida AT, Rutowitsch M, De Castro IA, Silveira VL, Gobatto DO, et al. Multicenter, double-blind study of the efficacy of injections with botulinum toxin reconstituted up to six consecutive weeks before application. Dermatol Surg. 2003;29:523-9.
9. Carruthers A, Carruthers J, Cohen J. Dilution volume of botulinum toxin for the treatment of glabellar rhytides: Does it matter? Dermatol Surg. 2007;33:S97-S104.
10. Hsu TS, Dover JS, Arndt KA. Effect of volume and concentration on the diffusion of botulinum exotoxin A. Arch Dermatol. 2004;140:1351-4.
11. Carruthers A, Bogle M, Carruthers JD, Dover JS, Arndt KA, Hsu TS, et al. A randomized, evaluator-blinded, two-center study of the safety and effect of volume on the diffusion and efficacy of botulinum toxin in the treatment of lateral orbital rhytides. Dermatol Surg. 2007;33:567-71.
12. Flynn TC, Carruthers A, Carruthers J. Surgical pearl: The use of the Ultra-Fine II short needle 0.3-cc insulin syringe for botulinum toxin injections. J Am Acad Dermatol. 2002;46:931-3.
13. Alam M, Dover JS, Arndt K. Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative. Arch Dermatol. 2002;138:510-14.
14. Kwiat DM, Bersani TA, Bersani A. Increased patient comfort utilizing botulinum toxin reconstituted with preserved versus nonpreserved saline. Ophthal Plast Reconstr Surg. 2004;20:186-9.
15. Vadoud-Seyedi J, Simonart T. Treatment of axillary hyperhidrosis with botulinum toxin reconstituted in lidocaine or in normal saline: A randomized, side-by-side, double-blind study. Br J Dermatol. 2007;156:986-9.
16. Pena MA, Alam M, Yoo SS. Complications with the use of botulinum toxin for cosmetic applications and hyperhidrosis. Semin Cutan Med Surg. 2007;26:29-33.
17. Carruthers A, Carruthers J, Samireh S. Dose-ranging study of botulinum toxin in the treatment of glabellar rhytids in females. Dermatol Surg. 2005;31:414-22.
18. Carruthers J, Fagien S, Matarasso SL, the Botox Consensus Group. Consensus recommendations on the use of botulinum toxin in facial aesthetics. Plast Reconstr Surg. 2004;114:1S-22S.
19. Carruthers A, Carruthers J. Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids. Dermatol Surg. 2005;31:1297-303.
20. Levy JL, Pons F, Jouve E. Management of the ageing eyebrow and forehead: An objective dose - response study with botulimun toxin. J Eur Acad Dermatol Venereol. 2006;20:711-16.
21. Carruthers A, Carruthers J, Cohen J. A prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin in female subjects with horizontal forehead rhytides. Dermatol Surg. 2003;29:461-7.
22. Balikian RV, Zimbler MS. Primary and adjunctive uses of botulinum toxin in the periorbital region. Otolaryngol Clin North Am. 2007;40:291-303.
23. Carruthers A, Carruthers J. Eyebrow height after botulinum toxin to the glabella. Dermatol Surg. 2007;33:S26-S31.
24. Ahn MS, Catten M, Maas CS. Temporal brow lift using botulinum toxin A. Plast Reconstr Surg. 2000;105:1129-35.
25. Lowe NJ, Lask G, Yamauchi P, Moore D. Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin and placebo in patients with crow's feet. J Am Acad Dermatol. 2002;47:834-40.
26. Lowe NJ, Ascher B, Heckmann M, Kumar C, Fraczek S, Eadie N, et al. Botox facial aesthetics study team. Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin in subjects with crow's feet. Dermatol Surg. 2005;31:257-62.
27. Paloma V, Samper A. A complication with aesthetic use of Botox: Herniation of the orbital fat. Plast Reconstr Surg. 2001;107:1315-16.
28. Flynn TC, Carruthers J, Carruthers A. Botulinum-A toxin treatment of the lower eyelid improves infraorbital rhytides and widens the eye. Dermatol Surg. 2001;27:703-8.
29. Flynn TC, Carruthers J, Carruthers A, Clark II RE. Botulinum A toxin (BOTOX) in the lower eyelid: Dose-finding study. Dermatol Surg. 2003;29:943-51.
30. Carruthers J, Carruthers A. Aesthetic botulinum A toxin in the mid and lower face and neck. Dermatol Surg. 2003;29:468-76.
31. Semchyshyn N, Sengelmann RD. Botulinum toxin A treatment of perioral rhytides. Dermatol Surg. 2003;29:490-5.
32. Brandt FS, Boker A. Botulinum toxin for the treatment of neck lines and neck bands. Dermatol Clin. 2004;22:159-66.
33. Matarasso A, Matarasso SL, Brandt FS, Bellman B. Botulinum A exotoxin for the management of platysma bands. Plast Reconstr Surg. 1999;103:645-52.
34. Kane MA. Nonsurgical treatment of platysmal bands with injection of botulinum toxin A. Plast Reconstr Surg. 1999;103:656-63.
35. Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol. 2000;43:240-59.
36. Hsu T, Dover JS, Kaminer MS, Arndt KA, Tan M. Why make patients exercise facial muscles for 4 hours after botulinum toxin treatment? Arch Dermatol. 2003;139:948.